UK and Ireland dates
USA and Canada dates
Australia and NZ dates
Rest Of World dates
Featured Testimonials
THOR on Facebook
THOR on Twitter
THOR on LinkedIn
THOR on Instagram
THOR on YouTubeCategories
Essays
Links
Category Archives: Special Feature
What makes THOR probes special (why we test LEDs)
Posted in Special Feature, Video of the Week
on What makes THOR probes special (why we test LEDs)
Roundup of the decade – a big thank you note
Wow, what a decade it has been for LLLT. Credibility is critical for acceptance by reimbursement and regulatory authorities as well as doctors and therapists. In the last ten years over 1,000 papers have been published that build on the work of the early pioneers. Highlights of this decade include: FDA clearance, publication in high impact factor journals such as Nature, Pain, PNAS, Spine, Muscle and Nerve, Stroke, Blood and, of course, The Lancet. Output from world renowned institutions including Harvard Medical School, NASA and the US Navy add further reassurance.
Posted in Special Feature
2 Comments
The next decade of LLLT – the barriers to mainstream adoption
Because LLLT modulates cellular oxidation and energy production it could potentially affect a wide range of diseases, injuries or other dysfunctions in the body.
By the end of the next decade, it is possible LLLT may be used in almost every department of every hospital (and every medicine cabinet of every home).
Given the amount of good quality research published over the last decade, why isn’t it part of mainstream medicine already?
Posted in PBM/LLLT, Special Feature, THE FUTURE OF PBM/LLLT
on The next decade of LLLT – the barriers to mainstream adoption
Latest THOR newsletter
Posted in Special Feature
on Latest THOR newsletter
LOW LEVEL LASER / PHOTOBIOMODULATION DOSIMETRY. WHAT ARE THE THRESHOLDS AND WHAT ARE THE LIMITS?
James D Carroll FRSM, AMInstP, THOR Photomedicine Ltd, United Kingdom
Photobiomodulation includes biostimulation and bioinhibition. In vitro, in vivo and clinical studies have established that there are radiant intensities and energy thresholds below which no significant cellular stimulation or clinical effects are achieved. Conversely there are radiant intensities and total fluence thresholds above which cellular stimulation decreases from its peak effect and inhibition is achieved. Many dose-ranging studies have been published using a variety of laboratory and clinical models and most suggest that cellular stimulation is achieved at radiant intensities in the range of 5 – 50mW/cm2 (at the target tissue ) and that exceeding these levels can inhibit cellular function.
So what is the role of the higher intensity laser products that appear to be popular with some clinicians and their patients ?
Posted in PBM/LLLT, Special Feature
on LOW LEVEL LASER / PHOTOBIOMODULATION DOSIMETRY. WHAT ARE THE THRESHOLDS AND WHAT ARE THE LIMITS?